INTERVENCIÓN CORONARIA PERCUTÁNEA EN PERSPECTIVA.

Pablo Moreno Franco

Submitted October 12, 2024

Published 2026-04-06

Artículos de Investigación

Vol. 15 No. 2 (2002): Revista Médico Científica

PERCUTANEOUS CORONARY INTERVENTION IN PERSPECTIVE.

Pablo Moreno Franco⁺⁻

PDF (Español (España))

Citación:

DOI: ND

Published: 2026-04-06

How to Cite

1.

Moreno Franco P. PERCUTANEOUS CORONARY INTERVENTION IN PERSPECTIVE. . rmc [Internet]. 2026 Apr. 6 [cited 2026 Oct. 18];15(2):83-7. Available from: https://revistas.up.ac.pa/index.php/revistamedicocientifica/article/view/5915

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Abstract

Percutaneous coronary intervention (PCI) is an important grou p of technologies for diagnosis and treatment of patients with many types of cardiovascular disease. PCI's have become a field with ma ny new applications , although - as any other procedure - they still have some limitations. We are far from having practical experience on corona ry interventions, but we have had the opportunity of receiving brand new information from important authors on this subject. We have attended lectures , broadcasts of live cases and we have reviewed rec ent articles. That is why we want to show our impressi on on the actual and future applications of these techniques. We will focus our discussion in the actual use of these techniques in terms of general considerations regarding PCl's, including the future role of coatedstents and the treatment of small vessel disease; as well as the promises of computers and robotic surgery to facilitate complex endoscopic procedures.

Downloads

Download data is not yet available.

References

Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-8.
American Heart Association. 2001 Heart and Stroke Statistical Update. 2001; Dallas, TX: American Heart Association.
Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82:739-50.
Popma JJ. Featured Lecture of the Day: Interventions-2002 New Devices, New Trials and New Developments. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Buchbinder M. New Modalities for PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Yeung A. Complications and Emergencies During PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Waksman R, Ghazzal Z, Baim D, Steenkiste A, Yeh W, Detre K, King III S for the NACI investigators: Myocardial Infarction as a Complication or New Interventional Devices. Am J Cardiol 1996; 78:751-6.
Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A Randomized Comparison of Coronary Stent Placement and Balloon Angioplasty Treatment of CAD. N Engl J Med 1994; 331:496-501.
Garratt KN. In-stent Restenosis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Infusion prior to stenting trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.
Mehran R, Mintz GS, Popma JJ, et al. Mechanism of restenosis and redilatation within coronary stents: quantitative angiographic assessment. Am J Cardiol 1996; 76:618-22.
Ferguson J. Pharmacology for Vascular Intervention. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Sanborn T. Molecular Biology-Gene Therapy and Angiogenesis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Nabel EG, Plautz GE, Nabel GJ. Gene Therapy and Restenosis. In: Schwartz RS, ed. Coronary Restenosis. Boston: Blackwell Scientific, 1993:279-93.
Wilensky R, Jean-Francois T, Shigenori I, et al. Heparin Infusion prior to Stenting Trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.
Marchena E. Small Vessel and Diffuse Disease. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigator. J Am Coll Cardiol 1998; 31:307-11.
Cohen MG, Kong DF, Warner JJ, et al. Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. Am J Cardiol 2000; 85:446-50.
Doucet S, Schalij MJ, Mathy CMM. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001; 104:2029-33.
Mack MJ. Future of cardiac surgery. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Mack MJ. Minimally Invasive and Robotic Surgery. JAMA 2001; 285:568-72.
Lincoff AM, Popma JJ, Ellis SG, et al. Percutaneous support devices for high-risk or complicated coronary angioplasty. J Am Coll Cardiol 1991; 17:770.

Keywords

PDF (Español (España))

Resumen visto - 152 veces
PDF (Español (España)) descargado - 1

Licencia

Content Top

[1] Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-8.

[2] American Heart Association. 2001 Heart and Stroke Statistical Update. 2001; Dallas, TX: American Heart Association.

[3] Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82:739-50.

[4] Popma JJ. Featured Lecture of the Day: Interventions-2002 New Devices, New Trials and New Developments. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[5] Buchbinder M. New Modalities for PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[6] Yeung A. Complications and Emergencies During PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[7] Waksman R, Ghazzal Z, Baim D, Steenkiste A, Yeh W, Detre K, King III S for the NACI investigators: Myocardial Infarction as a Complication or New Interventional Devices. Am J Cardiol 1996; 78:751-6.

[8] Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A Randomized Comparison of Coronary Stent Placement and Balloon Angioplasty Treatment of CAD. N Engl J Med 1994; 331:496-501.

[9] Garratt KN. In-stent Restenosis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[10] Infusion prior to stenting trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.

[11] Mehran R, Mintz GS, Popma JJ, et al. Mechanism of restenosis and redilatation within coronary stents: quantitative angiographic assessment. Am J Cardiol 1996; 76:618-22.

[12] Ferguson J. Pharmacology for Vascular Intervention. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[13] Sanborn T. Molecular Biology-Gene Therapy and Angiogenesis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[14] Nabel EG, Plautz GE, Nabel GJ. Gene Therapy and Restenosis. In: Schwartz RS, ed. Coronary Restenosis. Boston: Blackwell Scientific, 1993:279-93.

[15] Wilensky R, Jean-Francois T, Shigenori I, et al. Heparin Infusion prior to Stenting Trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.

[16] Marchena E. Small Vessel and Diffuse Disease. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[17] Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigator. J Am Coll Cardiol 1998; 31:307-11.

[18] Cohen MG, Kong DF, Warner JJ, et al. Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. Am J Cardiol 2000; 85:446-50.

[19] Doucet S, Schalij MJ, Mathy CMM. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001; 104:2029-33.

[20] Mack MJ. Future of cardiac surgery. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[21] Mack MJ. Minimally Invasive and Robotic Surgery. JAMA 2001; 285:568-72.

[22] Lincoff AM, Popma JJ, Ellis SG, et al. Percutaneous support devices for high-risk or complicated coronary angioplasty. J Am Coll Cardiol 1991; 17:770.

Cover image